STOCK TITAN

MariMed insider filing: 111,112 RSUs vested; 32,612 shares withheld

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

MariMed (MRMD) insider update: Chief Operating Officer Timothy Shaw reported routine equity transactions on 10/27/2025. He converted 111,112 restricted stock units into common stock (Code M; price $0), then had 32,612 shares withheld to cover taxes (Code F) at $0.1579 per share. Following these transactions, Shaw beneficially owns 9,133,912 shares directly. He also has 2,000,000 shares held indirectly by the Shaw Family Trust. The RSUs were granted on October 27, 2022 and are now fully vested, with no unvested RSUs remaining under that grant.

Positive

  • None.

Negative

  • None.

Insights

Routine RSU vesting with tax withholding; neutral impact.

The filing shows an RSU vest (Code M) of 111,112 shares at $0, typical for time-based awards converting one-for-one into common stock. The subsequent tax event (Code F) withheld 32,612 shares at $0.1579 to satisfy withholding obligations, a standard non-cash settlement.

Post-transaction holdings are 9,133,912 shares direct and 2,000,000 indirect via a trust. This is administrative and does not signal new open-market buying or selling. Actual market impact depends on any future trades, which are not indicated in the excerpt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Shaw Timothy

(Last) (First) (Middle)
C/O MARIMED INC.
10 OCEANA WAY

(Street)
NORWOOD, MA 02062

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/27/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock 10/27/2025 M 111,112 A $0(1) 9,166,524 D
Common stock 10/27/2025 F 32,612(2) D $0.1579 9,133,912 D
Common stock 2,000,000 I By the Shaw Family Trust(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (RSU) (1) 10/27/2025 M 111,112 (4) (4) Common Stock, par value $.001 per share 111,112 $0 0 D
Explanation of Responses:
1. RSUs convert to shares of common stock on a one-for-one basis.
2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
3. The Reporting Person's spouse is the trustee of the trust and the shares held in the trust are for the benefit of the Reporting Person's children. The trust is an irrevocable trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
4. These RSUs were granted on October 27, 2022; there are no unvested RSUs remaining under this grant in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
Remarks:
/s/ Timothy Shaw 10/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MRMD's COO report in the latest Form 4?

Timothy Shaw converted 111,112 RSUs to common stock (Code M) and had 32,612 shares withheld for taxes (Code F) at $0.1579.

How many MRMD shares does Timothy Shaw hold after the transactions?

He holds 9,133,912 shares directly and 2,000,000 shares indirectly via the Shaw Family Trust.

Were these MRMD transactions open-market buys or sells?

No. They reflect RSU vesting (Code M) and tax withholding (Code F), not open-market trades.

What was the source and status of the RSUs in MRMD's filing?

The RSUs were granted on October 27, 2022 and are now fully vested with none remaining unvested.

What prices were used in the MRMD Form 4 entries?

The RSU conversion was at $0; tax withholding occurred at $0.1579 per share.

What is the relationship of the indirect MRMD holdings?

The 2,000,000 shares are held by the Shaw Family Trust; beneficial ownership is disclaimed as described.
Marimed

OTC:MRMD

MRMD Rankings

MRMD Latest News

MRMD Latest SEC Filings

MRMD Stock Data

56.49M
280.32M
14.7%
0.24%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Norwood